| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.573 | 23.420 | 17.567 | 0 | 0 | 0 | 10.809 | 35.655 | 40.768 | - |
| Total Income - EUR | 33.573 | 23.420 | 17.567 | 0 | 0 | 0 | 10.809 | 35.655 | 40.768 | - |
| Total Expenses - EUR | 764 | 178 | 167 | 23 | 0 | 0 | 72 | 317 | 524 | - |
| Gross Profit/Loss - EUR | 32.808 | 23.242 | 17.400 | -23 | 0 | 0 | 10.737 | 35.339 | 40.244 | - |
| Net Profit/Loss - EUR | 31.801 | 22.539 | 16.873 | -23 | 0 | 0 | 10.412 | 34.549 | 33.934 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Pharma Trade Consulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 37.090 | 35.624 | 39.083 | 38.344 | 37.601 | 36.888 | 46.683 | 81.497 | 69.235 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.511 | - |
| Cash | 37.090 | 35.624 | 39.083 | 38.344 | 37.601 | 36.888 | 46.683 | 81.497 | 41.723 | - |
| Shareholders Funds | 36.922 | 35.356 | 39.083 | 38.344 | 37.601 | 36.888 | 46.483 | 81.176 | 33.982 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 168 | 268 | 0 | 0 | 0 | 0 | 200 | 321 | 35.252 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Pharma Trade Consulting Srl